Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11110%2F15%3A10296534" target="_blank" >RIV/00216208:11110/15:10296534 - isvavai.cz</a>

Alternative codes found

RIV/00064165:_____/15:10296534

Result on the web

<a href="http://dx.doi.org/10.1517/14656566.2015.1059822" target="_blank" >http://dx.doi.org/10.1517/14656566.2015.1059822</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1517/14656566.2015.1059822" target="_blank" >10.1517/14656566.2015.1059822</a>

Result language

angličtina

Original language name

Conventional induction and maintenance treatment of Antineutrophil cytoplasmic antibodies-associated vasculitis - still of value for our patients?

Original language description

Introduction: Antineutrophil cytoplasmic antibodies-associated vasculitis (AAV) is a group of autoimmune diseases characterized by the necrotizing inflammation of small vessels and associated with the antineutrophil cytoplasmic antibodies. Treatment of AAV can be divided into the induction phase aimed at achieving remission of the disease and the maintenance phase aimed at prevention of relapses. Long-term outcome of AAV dramatically improved with the introduction of cyclophosphamide. Recent clinical studies resulted in the reduction of the cumulative dose of cyclophosphamide and introduction of new treatment options, namely B-cell-depleting antibody rituximab, into both induction and maintenance treatment. This paper aims to evaluate the current roleof the conventional induction and maintenance treatment in view of the gradually increasing use of rituximab. Areas covered: This paper provides an overview of the main clinical studies in induction and maintenance treatment of adult pati

Czech name

—

Czech description

—

Type

J_x - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

CEP classification

FE - Other fields of internal medicine

OECD FORD branch

—

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2015

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

Expert Opinion on Pharmacotherapy

ISSN

1465-6566

e-ISSN

—

Volume of the periodical

16

Issue of the periodical within the volume

11

Country of publishing house

GB - UNITED KINGDOM

Number of pages

20

Pages from-to

1683-1702

UT code for WoS article

000358458400011

EID of the result in the Scopus database

2-s2.0-84936946970